Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab. acbr. 2021;5(6):972-982. Accessed September 20, 2026. https://www.fortunejournals.org/ojs/index.php/acbr/article/view/14882